Exploring The Link Between TSHR Gene Polymorphism and Thyroid Function Parameters in Thyroid Disorder Patients
DOI:
https://doi.org/10.15218/edj.2025.13Keywords:
ARMS-PCR with TFTs, Hormone levels, hyperthyroidism, polymorphism, TSHR geneAbstract
Background and Objectives: Most common autoimmune thyroid diseases are Hashimoto's thyroiditis and Graves' disease which are caused by immune system and genetic factors. In this study the association between the thyroid function test (TFT) values and the TSHR gene polymorphism c.1349G>T will be investigated, which leads to a p.Arg450Leu amino acid change, in patients with thyroid disorders.
Methods: A cross-sectional study investigating, 50 thyroid dysfunction patients and 50 samples of healthy controls participated. The immunoassay was used to measure the serum levels of TSH, FT3, and FT4. Allele-specific ARMS-PCR was used to genotype the TSHR c.1349G>T (p.Arg450Leu) polymorphism.
Results: Hyperthyroid patients displayed suppressed TSH and raised FT3/FT4 levels, and hypothyroid patients displayed considerably elevated TSH and decreased FT3/FT4 levels. The hyperthyroid group had a higher frequency of the c.1349G>T variation of the TSHR gene (p.Arg450Leu) than the hypothyroid and control groups. The T allele was found to be statistically significantly associated with a higher incidence of hyperthyroidism (P<0.01). Serum TSH levels did not significantly differ between homozygous and heterozygous carriers of the mutation.
Conclusion: The research suggests a possible relationship between thyroid dysfunction, specifically hyperthyroidism, and the TSHR c.1349G>T (p.Arg450Leu) polymorphism. Thyroid disease risk prediction and diagnosis accuracy may be improved by performing genetic screening.
References
Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99(1):39–51. https://doi.org/10.1093/bmb/ldr030
Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122(9):3035–43. https://doi.org/10.1172/jci60047
Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14(2):174–80. https://doi.org/10.1016/j.autrev.2014.10.016
Smith TJ, Hegedüs L. Graves’ disease. N Engl J Med. 2016;375(16):1552–65. https://doi.org/10.1056/nejmra1510030
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–421. https://doi.org/10.1089/thy.2016.0229
Rapoport B, McLachlan SM. The thyrotropin receptor in Graves’ disease. Thyroid. 2014;24(3):401–10 https://doi.org/10.1089/thy.2007.0170
Davies, T. F., Yin, X. & Latif, R. Te genetics of the thyroid stimulating hormone receptor: History and relevance. Tyroid 20(7), 727–736 (2010). https://doi.org/10.1089/thy.2010.1638
Peeters, R. P. & Toor, H. V. Polymorphism in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in health subjects. J. Clin. Endocrinol. Metab. 88(6), 2880– 2888 (2003). https://doi.org/10.1210/jc.2002-021592
Chaker, L., Bianco, A. C., Jonklaas, J. & Peeters, R. P. Hypothyroidism. Lancet 390(10101), 1550–1562 (2017). https://doi.org/10.1016/s0140-6736(17)30703-1
Fang Y, Sun F, Zhang RJ, Zhang CR, Yan CY, Zhou Z, Zhang QY, Li L, Ying YX, Zhao SX, Liang J. Mutation screening of the TSHR gene in 220 Chinese patients with congenital hypothyroidism. Clinica Chimica Acta. 2019 Oct 1;497:147-52. https://doi.org/10.1016/j.cca.2019.07.031
Alzahrani, A. S. et al. Diagnosis and management of hypothyroidism in Gulf Cooperation Council (GCC) countries. Adv. Ter. 37(7), 3097–3111 (2020). https://doi.org/10.1007/s12325-020-01382-2
Grixti L, Lane LC, Pearce SH. The genetics of Graves’ disease. Reviews in endocrine and metabolic disorders. 2024 Feb;25(1):203-14. https://doi.org/10.1007/s11154-023-09848-8
Duprez L, Parma J, Van Sande J, Rodien P, Dumont JE, Vassart G, Abramowicz M. TSH receptor mutations and thyroid disease. Trends in Endocrinology & Metabolism. 1998 May 1;9(4):133-40. https://doi.org/10.1016/s1043-2760(98)00036-8
Pujol-Borrell R, Giménez-Barcons M, Marín-Sánchez A, Colobran R. Genetics of Graves’ disease: special focus on the role of TSHR gene. Hormone and Metabolic Research. 2015 Sep;47(10):753- 66. https://doi.org/10.1055/s-0035-1559646
Latif R, Morshed SA, Davies TF. Thyroid-stimulating hormone receptor: An example of a multi- functional G protein-coupled receptor. Endocr Pract. 2009;15(1):40–6. https://doi.org/10.1371/journal.pone.0075100
Szkudlinski MW, Fremont V, Ronin C, Weintraub BD. Thyroid-stimulating hormone and thyroid- stimulating hormone receptor structure-function relationships. Physiological reviews. 2002 Apr 1;82(2):473-502. https://doi.org/10.1152/physrev.00031.2001
Bhanothu, Venkanna, Simeone Fernandes, Sudha Chandrashekhar Rao, Rachna Keshwani, Shagun W. Shagun, Suchitra Surve, Shailesh Pande, Sudhakar DVS, Neha Minde, and Shivamkumar Sriwas. "Use of Allele-Specific-Amplification Refractory Mutation System– Polymerase Chain Reaction for the Detection of Thyroid-Stimulating Hormone Receptor Gene Mutation in an Indian Family with Thyroid Dyshormonogenesis." Annals of Neonatology 6, no. 1 (2024): 7-36. Here is the direct link to the article: https://anj.journals.ekb.eg/article_317051.html
Davies TF, Yin X, Latif R. The genetics of the thyroid stimulating hormone receptor: history and relevance. Thyroid. 2010 Jul 1;20(7):727-36. https://doi.org/10.1089/thy.2010.1638
Morshed SA, Davies TF. Graves’ disease mechanisms: The role of stimulating, blocking, and cleavage region TSH receptor antibodies. Horm Metab Res. 2015;47(10):727–34. https://doi.org/10.1055/s-0035-1559633
Brand OJ, Gough SC. Genetics of thyroid autoimmunity and the role of TSHR. Mol Cell Endocrinol. 2010;322(1–2):135–43. https://doi.org/10.1016/j.mce.2010.01.013
Bahn RS. Current insights into the pathogenesis of Graves’ ophthalmopathy. Horm Metab Res. 2015;47(10):773–8. https://doi.org/10.1055/s-0035-1555762
Fujii A, Inoue N, Watanabe M, Kawakami C, Hidaka Y, Hayashizaki Y, Iwatani Y. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves’ Disease, Especially Intractable Disease, and of Hashimoto's Disease. Thyroid. 2017 Jan 1;27(1):111-9. https://doi.org/10.1089/thy.2016.0345
Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun. 2009;32(3–4):231–9.https://doi.org/10.1016/j.jaut.2009.02.007
Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity. 2003 Sep 1;36(6-7):367-79. https://doi.org/10.1080/08916930310001603037
Costa-e-Sousa RH, Hollenberg AN. Minireview: the neural regulation of the hypothalamic- pituitary-thyroid axis. Endocrinology. 2012 Sep 1;153(9):4128-35. https://doi.org/10.1210/en.2012-1467
Davies TF, Yin X, Latif R. The genetics of the thyroid stimulating hormone receptor: history and relevance. Thyroid. 2010 Jul 1;20(7):727-36. https://doi.org/10.1089/thy.2010.1638
Razmara E, Salehi M, Aslani S, Bitaraf A, Yousefi H, Colón JR, Mahmoudi M. Graves’ disease: introducing new genetic and epigenetic contributors. Journal of molecular endocrinology. 2021 Feb 1;66(2):R33-55. https://doi.org/10.1530/JME-20-0078.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Hawzhin Hussein Hayder, Ashti Mohammad Amin Said (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in Erbil Dental Journal is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).
